Illustration: Maura Losch/Axios
Webster Equity plans to take Bristol Hospice to market later this year, three sources familiar tell Axios Pro.
Inside the room: Goldman and Guggenheim were co-mandated to sell the business, which will be marketed on about $140 million of EBITDA.
